Chapter 51. Toxoplasmosis

  1. John T. Queenan MD Professor Chairman Emeritus2,
  2. John C. Hobbins MD Professor of Obstetrics3 and
  3. Catherine Y. Spong MD Chief4
  1. Shad Deering MD

Published Online: 30 APR 2009

DOI: 10.1002/9781444312904.ch51

Protocols for High-Risk Pregnancies, Fourth Edition

Protocols for High-Risk Pregnancies, Fourth Edition

How to Cite

Deering, S. (2009) Toxoplasmosis, in Protocols for High-Risk Pregnancies, Fourth Edition (eds J. T. Queenan, J. C. Hobbins and C. Y. Spong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444312904.ch51

Editor Information

  1. 2

    Department of Obstetrics and Gynecology, Georgetown University School of Medicine, 3257 N Street NW, Washington, DC 20007, USA

  2. 3

    University of Colorado Health Sciences Center, Department of Obstetrics and Gynecology, 4200 East 9th Avenue, B-198, Denver, CO 80262, USA

  3. 4

    National Institute of Child Health and Human Development, Center for Developmental Biology and Perinatal Medicine, Pregnancy and Perinatology Branch, National Institutes of Health, 6100 Executive Bivd, Bethesda, MD 20892-7510, USA

Author Information

  1. Department of Obstetrics and Gynecology, Madigan Army Medical Center, Tacoma, Washington, DC 98431, USA

Publication History

  1. Published Online: 30 APR 2009
  2. Published Print: 9 SEP 2005

ISBN Information

Print ISBN: 9781405125796

Online ISBN: 9781444312904

SEARCH

Keywords:

  • streptococcus;
  • Toxoplasma gondii - a protozoan parasite;
  • maternal infection;
  • immunoglobulin M antibodies - diagnosing acute infection;
  • fetal infection;
  • polymerase chain reaction (PCR) - amniotic fluid testing;
  • pericardial or pleural effusions;
  • pyrimethamine and sulfadiazine - folic acid antagonists

Summary

This chapter contains sections titled:

  • Introduction and Pathophysiology

  • Diagnosis

  • Treatment

  • Complications

  • Follow-up

  • Prevention

  • Conclusions

  • References